· 自动抓取 · 最新研究 · 1 分钟阅读
Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies
Leukemia, Published online: 07 July 2026; doi:10.1038/s41375-026-03012-2Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chro
Leukemia, Published online: 07 July 2026; doi:10.1038/s41375-026-03012-2Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies
本文自动抓取自 Leukemia，原文链接：Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies
原文发布日期：2026-07-07
